Cara Therapeutics
- Pharmaceutical Preparations
- Stamford, Connecticut
Compensation history
Top executives at Cara Therapeutics received an average of $2M per person in annual compensation from 2013 to 2023.
By year
- 2021
DC$10MDerek ChalmersFormer President and Chief Executive OfficerCP$10MChristopher PosnerPresident and Chief Executive OfficerFM$2MFrédérique MenzaghiChief Scientific Officer and SeniorJG$2MJoana GoncalvesChief Medical OfficerST$2MScott TerrillionGeneral Counsel, Secretary and Chief Compliance OfficerTR$810KThomas ReillyChief Financial Officer
Executives
We found 11 executives who work or worked at Cara Therapeutics.
Christopher Posner
Cara Therapeutics
Chief Executive Officer
Ryan Maynard
Cara Therapeutics
Chief Financial Officer
Joana Goncalves
Cara Therapeutics
Chief Medical Officer
Derek Chalmers
Cara Therapeutics
Chief Executive Officer
Thomas Reilly
Cara Therapeutics
Chief Financial Officer
Frédérique Menzaghi
Cara Therapeutics
Chief Scientific Officer
Scott Terrillion
Cara Therapeutics
General Counsel
Mani Mohindru
Cara Therapeutics
Chief Financial Officer
News
Cara Therapeutics CEO Christopher Posner's 2023 pay rises 16% to $2.9M
April 22, 2024
Cara Therapeutics CEO Christopher Posner's 2022 pay falls 75% to $2.5M
April 20, 2023
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019
About Cara Therapeutics
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 400 Atlantic Street, Suite 500, Stamford, Connecticut 06901
- 203-406-3700
- December 31
- Former names
- Cara Therapeutics Inc